Proinflammatory cytokines, including tumor necrosis factor (TNF)a, have been recognized as important physiopathogenetic factors in the initiation and continuation of inflammatory cardiomyopathies. Experimental and preliminary human studies have demonstrated that TNFa plays a crucial role in enteroviral-induced myocarditis. In this study, we investigated the expression of TNFa and both its receptors (TNFRI and TNFRII) in both viral and nonviral myocarditis. Myocardial expression of TNFa was then correlated with different clinical and pathologic findings. TNFa expression was investigated in endomyocardial biopsies obtained from 38 patients with myocarditis and from eight control subjects by using reverse transcriptase-polymerase chain reaction (PCR) and immunohistochemistry. Viral etiology was diagnosed by PCR in 20 cases: enterovirus in seven, Epstein-Barr virus in four, hepatitis C virus in three, adenovirus in two, influenza virus in two, cytomegalovirus in one, and double infection adenovirus and enterovirus in one. Immunohistochemistry was also used to analyze both TNFa receptors (RI and RII). A semiquantitative analysis was employed (score 0-3) for necrosis, inflammation, fibrosis and immunohistochemical findings. TNFa mRNA and TNFa protein were significantly more present in viral myocarditis than in nonviral myocarditis (16/20 vs 3/18, P ¼ 0.001). Remarkable immunostaining was observed for both receptors, particularly TNFRI. Histological analysis revealed that myocardial necrosis (mean score 1.89 vs 1.15, P ¼ 0.01) and cellular infiltration (mean score 2.26 vs 1.78, P ¼ 0.05) were more prominent in TNFa-positive cases. Among TNFa-positive cases, the greater TNFa mRNAs, the more impaired was cardiac function. Our findings suggest that the expression of TNFa may play an important role in the pathogenesis of viral myocarditis of any etiology and may influence the severity of cardiac dysfunction. Cytokine effects are more strictly linked to overexpression of TNFRI.
Myocarditis is an inflammation of the myocardium caused by infection and/or autoimmune reactions that may progress to dilated cardiomyopathy and heart failure. 1, 2 Several studies, using a molecular approach, have reported that different cardiotropic viruses have been implicated in most cases of human myocarditis and cardiomyopathy. 3, 4 Whether myocyte damage in the early phase of the disease is primarily linked to the viral presence or to immunomediated damage is still under discussion; however, it is now accepted that the progression of the disease is mainly sustained by immunomechanisms. 5 The presence of heterogeneous inflammatory cell populations in inflammatory cardiomyopathy implies the existence of a complex, cytokine-rich microenvironment that may contribute to the pathogenesis. 6, 7 Among cytokines, tumor necrosis factor (TNF)a is thought to play a pivotal role in the development and progression of myocarditis, [8] [9] [10] [11] [12] particularly those that are enteroviral related. 8, 10 Previous clinical works have demonstrated that there is an association between depressed myocardial function and elevated TNFa mRNA and protein levels either in plasma or in the myocardium of patients (pts) with myocarditis and dilated cardiomyopathy. 13, 14 TNFa elicits its biological effects by binding to two distinct cell surface receptors with approximate molecular masses of 55 kDa (TNFRI) and 75 kDa (TNFRII), both expressed in human cardiac myocytes. [15] [16] [17] TNFRI has been shown to initiate negative inotropic effects of TNFa, including the cytotoxic effects in adult cardiac myocytes. 13 In this study, we investigated the expression of TNFa and its receptor TNFRI and TNFRII in endomyocardial tissues of pts suffering from viral and nonviral myocarditis by using a reverse transcription (RT)-polymerase chain reaction (PCR) method and immunohistochemistry, respectively. Cytokine expression was then correlated with the main clinicohemodynamic and pathologic parameters.
Materials and methods

Patients
A total of 40 endomyocardial biopsies (EMBs) from 38 pts affected by viral and nonviral myocarditis were randomly chosen from pt records in the Cardiac Units of Padua and Rome University Hospitals in the period 1999-2000. Pts included 27 males and 11 females with a mean age of 36715 years (range 15-76 years). Myocarditis was diagnosed on the basis of clinical symptoms (eg upper respiratory illness, fever, chest pain, arrhythmias, murmurs, cardiomegaly, elevated erythrocyte sedimentation rate, leukocytes, conduction disturbances) in conjunction with histologic signs of inflammatory infiltrate and myocyte damage, according to the Dallas criteria. 18, 19 Pts were excluded if there was any angiographic evidence of coronary heart disease, ischemic changes during exercise testing, systemic hypertension, concomitant systemic or endocrine disease that might cause impairment of left ventricular function, or excessive alcohol consumption. Specific types of myocarditis, such as rheumatic, septic, mycotic, eosinophilic, giant cell types, and myocarditis associated with collagen disease and sarcoidosis, were not considered in this study.
A full clinical assessment was performed in all pts, including familiar and personal history of preceding viral illnesses, period of the infection (season), time between onset of symptoms and EMB, and complete physical examination with functional classification according to the New York Heart Association (NYHA). All pts were followed up at 4-week to 3-month intervals. At each visit, clinical assessment, ECG, and 2D echocardiography were performed (Table 1) .
Myocardial biopsies from eight donor hearts before transplantation were added as controls (mean age of 47.8 years; range 33-56 years).
Right ventricular EMBs tissues were obtained from all pts by the standard percutaneous right femoral approach using a Cordis bioptome. 20 In all, 4-5 tissue samples were retrieved from each pt. Four of these were fixed in 10% buffered formalin and embedded in paraffin after dehydration in a graded alcohol series. The remaining sample was frozen immediately after biopsy at À801C and used for molecular analysis. In four pts, one heart transplanted (case 1) and three autoptic cases (cases 11, 27, 36) , the whole heart has been also evaluated.
All invasive cardiac examinations were approved by the Ethical Committee of both Institutions and performed after informed consent.
Morphological Analyses and Viral Detection
For histology, 4-mm thick sections were cut and stained with hematoxylin and eosin, Weigert van Gieson's, and Heidenhein trichrome and examined by light microscopy.
Immunohistochemistry for the characterization of inflammatory infiltrate was carried out by use of the following antibodies (all Dako Glostrup, Denmark): CD45 (1:20), CD43 (1:40), CD45RO (1:100), CD20 (1:100), CD3 (1:50), CD68 (1:50), CD4 (1:100), and CD8 (1:100). The immunoreaction products were developed using the avidin-biotin-peroxidase complex method. 21 In each biopsy, necrosis, the intensity of the infiltrate as well as the extension of fibrosis were graded semiquantitatively as follows: 22 score 0 ¼ absent; score 1 ¼ mild; score 2 ¼ moderate; score 3 ¼ severe.
For viral detection, total RNA and DNA were extracted from EMBs of pts and control subjects by using the modified RNAzol method. 23 The oligonucleotides used to ascertain the quality of extracted RNA or DNA were complementary to the mRNA glyceraldehyde-3-phosphate dehydrogenase (3GPDH) and b-globin gene, respectively. 24, 25 PCR analysis was repeated in all negative viral amplicons by using paraffin-embedded samples in order to exclude false-negative due to only one frozen processed sample. As for the paraffinembedded biopsies, the dried tissue pellets obtained after deparaffinizzation with xylene, were digested in two different lysis solutions for RNA 26 and DNA. 27 PCR/RT-PCR or nested-PCR and sequencing analysis were used to detect and characterize well-known cardiotropic viruses. Direct cycle sequencing of PCR products was carried out on an ABI model 310 DNA sequencer as previously described. 4 Sequence data were analyzed using the sequence analysis 2.1.2 and sequence navigator for sequence comparison.
Blast search was used to identify homology between sequences and all published DNA reported in the Gene Bank Data Base.
Intramyocardial TNFa
TNFa production (TNFa mRNA and TNFa protein) was investigated in each case of myocarditis and in controls. The cycle number (38 cycles) was chosen to ensure that the amount of products synthesized was proportional to the amount of specific mRNA in the original preparation.
Myocardial TNFa gene expression
Following PCR amplification, PCR products (15 ml) were subjected to electrophoresis on 2% agarose gels containing 0.03 mg/ml ethidium bromide. Among TNFa-positive pts, TNFa mRNA was assessed in 11 cases (in which adequate quantity of RNA was available) with different cardiac dysfunction: left ventricular ejection fraction (EF) o40% (NYHAZ3) in cases 1, 10, 11, 16, 28, and 32 vs EFZ40% (NYHAo3) in cases 19, 24, 26, 29, and 36. The quantification of transcript level was carried out by scanning photographs of gels and analyzing the area under peaks, using Quantity one Biorad software. Levels of mRNA expression were normalized by calculating them as a percentage of 3GPDH mRNA expression levels. 29 The band intensity for 3GPDH did not differ significantly within experiments. TNFa receptor (RII and RII) protein Serial sections were incubated with primary antibodies (monoclonal for TNFRI and RII both with a 1:250 dilution Genzyme Corp.) for 1 h and with secondary antibody for 10 min. The avidin-biotin complex incubation for 10 min and 3,3-diaminobenzidine were used for visualization. The same semiquantitative analysis (score 0-3) was used.
Statistical Analysis
Results are expressed as mean7s.e.m. One-way analysis of variance (ANOVA) and the Student's t-test for unpaired data were used for differences between subgroup. Selected variables were compared by linear regression analysis. The difference was considered statistically significant at a level of
Results
Clinicohemodynamic Features of Patient Cohort
The majority of pts (90%) showed symptoms lasting less than 24 weeks. In five pts (13%), a flu-like syndrome occurred at least 2 weeks before the onset of cardiac dysfunction, mainly in autumn and winter (23/38; 61%). A familiar history was reported in only two pts (5%). All pts had regional or global left ventricular dysfunction as assessed by echocardiography. An overview of the clinical data at baseline and follow-up is given in Table 1 . Adverse outcome occurred in 12 pts (7 deaths and 5 transplants). 
Morphological and Viral Findings
Myocarditis was active in 33 and borderline in five cases (Figure 1a) . Immunophenotypical characterization of inflammatory cells showed a prevalence of T lymphocytes (CD45RO and CD3) (Figure 1b) , including a moderate amount of cytotoxic lymphocytes (CD8 positive).
In all cases, the presence of sufficient target nucleic acid for PCR analysis was confirmed by amplification of b-globin for DNA and 3GPDH for RNA. Viral genomes were present in 20 pts including seven enteroviruses (35%), two adenoviruses (10%), four Epstein-Barr viruses (20%), two influenza viruses (10%), three hepatitis C viruses (15%), one cytomegalovirus (5%) and one double infection adenovirus-enterovirus (5%) ( Table 2 ). Sequencing analysis of the PCR products showed a high homology (495%) with published human viral genomes.
None of the control samples showed positive amplification for any cardiotropic viruses investigated in the study pts.
Myocardial TNFa and TNFa Receptors (RI and RII)
TNFa mRNA was detected in 19 out of 38 cases (50%) ( Table 2 ). There was no evidence of TNFa mRNA expression in the controls.
TNFa gene expression was seen in 16 out of 20 viral positive myocarditis cases (80%) vs only three out of 18 nonviral cases (17%) (P ¼ 0.001) (Figure 2a, b) .
TNFa immunostaining showed a marked positivity mainly in the myocardium obtained from viral cases (mean 1.8570.2 vs 0.670.2, P ¼ 0.002) and was detected in the cytoplasm of cardiac myocytes other than macrophages and mononuclear cells (Figure 3) .
Immunohistochemistry for TNFaRI and RII showed that both were overexpressed in TNFa-positive cases, A second follow-up EMBs was performed in two pts (cases 2 and 25); the expression of cytokine and its receptors showed similar results as the previous biopsy.
The large specimens taken from the whole heart of cases 1, 11, 27, and 36, showed the same expression of TNFa pathway as seen in the EMB of the same pts.
In the controls, TNFa immunostaining was always negative, while weak positivity was observed for TNFRI and RII.
There was a full concordance between the two pathologists: k-score for TNFa immunostaining was 0.88 and TNFRI and RII immunostaining 0.90 and 0.82, respectively.
Correlation between TNFa Expression and Pathological/Clinical Findings
Diffuse myocyte damage was observed more frequently in TNFa-positive myocarditis (score 1.89 vs 1.15, P ¼ 0.01). Only a trend for more severe inflammatory infiltrate was noted in TNFa-positive cases (score 2.26 vs 1.78, P ¼ 0.05, NS). Instead, no difference in terms of extension of fibrosis was noted between TNFa-positive and negative cases (P ¼ 1, NS).
No statistically significant correlation was found between TNFa PCR-positive and TNFa PCR-negative pts compared to various clinical parameters (familiar and personal history of preceding viral illnesses, season, time between onset of symptoms and EMB, EF, LVEDV, and NYHA). However, among TNFapositive cases, TNFa mRNAs were greater in pts with more impaired ejection fraction. Densitometric analysis revealed that the mRNA levels for TNFa were significantly increased in cases with more depressed EF compared to cases with less EF (3.2070.8 vs 0.2270.03, P ¼ 0.003) (Figure 6) .
No difference was observed between TNFa-positive and -negative in terms of survival (Table 1) . Conversely, an improvement of cardiac function was reported in TNFa-negative pts (NYHA class from 1.3 to 2.5, P ¼ 0.01).
Discussion
In this study, we have demonstrated that TNFa mRNA and protein are overexpressed in pts with viral myocarditis of any etiology.
Several studies have suggested that proinflammatory cytokines, such as TNFa, play an important role in the pathogenesis of myocarditis. Increased circulating TNFa has been reported in pts with myocarditis and cardiomyopathy. 9 The possible adverse impact of cytokines in myocarditis may cause an altered susceptibility to the disease thus impairing 32 showed that mice resistant to coxsackievirus infection develop inflammatory lesions when treated with TNFa or IL1. Similar results were found by Yamada et al, 33 who also showed that the treatment of mice with monoclonal anti-TNFa antibody before viral inoculation led to reduced mortality of infected animals. Recently, some authors have shown that cytokines upregulate coxsackie-adenovirus receptor (CAR) on human myocardium and that the level of CAR upregulation is a major determinant of susceptibility to cardiac infection by adenoviruses and coxsackie viruses. 34 Although the exact mechanism through which TNFa contributes to decreased contractile performance in myocarditis is not well known, a number of studies have emphasized the negative impact mediated by nitric oxide (NO). Finkel et al 35 showed that the depression of isolated papillary muscle contractile function caused by TNFa or IL6 was blocked when an L-arginine analogue was added as a specific inhibitor of NO synthase (NOS). Joe et al 36 demonstrated that shortening of myocytes is impaired when they are exposed to media in which macrophages are stimulated with lipopolysaccharide and that this can be blocked by inhibition of NOS.
TNFa and TNFa receptors in human myocarditis
TNFa, produced by activated macrophages and endothelial cells, can cause an increase of inducible NOS activity in cardiac myocytes, and can modulate inotropic responsiveness. 37 Other studies have 
F Calabrese et al suggested that inflammatory cytokines, including TNFa, may also cause a direct negative inotropic response. 38 Yokoyama et al 39 have shown that TNFa induces a direct negative inotropic effect in isolated ventricular myocytes of adult cat that is associated with a decrease in the Ca 2 þ transit, without changing the current L-type Ca 2 þ , and that it is not inhibited by blockers of NO production or arachidonic acid metabolism.
Although the majority of studies emphasize the negative influence of TNFa in different cardiovascular diseases, its role in the setting of myocarditis is still controversial. The amount and the time of endogenous TNFa released in cases of myocarditis seem today to be crucial for the beneficial and adverse effects of the cytokine. 40 At low concentrations, TNFa regulates paracrine and autocrine activity of leukocytes and endothelial cells, thus becoming an important monitor of the inflammatory response. TNFa enhances chemotaxis of macrophages and neutrophils, increases their phagocytic and cytotoxic activity 41 and promotes leukostasis by inducing increased expression of intracellular adhesion molecules and endothelial leukocyte adhesion molecules at sites of inflammation. Therefore, the presence of TNFa, as recently described by Wada et al, 42 plays a protective role in the early stage of encephalomyocarditis virus myocarditis, possibly through leukocyte recruitment, thus hindering viral replication. On the contrary at higher concentrations, TNFa production exceeds the number of its receptors located on the cell surface with an excess amount released into circulation. Once released, it produces devastating consequences not only in terms of multiorgan dysfunction but overall in the setting of cardiovascular system. 43, 44 One of the most important findings of this study was a significantly elevated level of expression of TNFa mRNAs and proteins in pts affected by viral myocarditis with lower EF and more impaired NYHA functional class.
The persistent myocardial overexpression of cytokine, as demonstrated in the follow-up biopsy or in the whole heart from pts who died or underwent heart transplantation, is an additional data suggesting that the cytokine is implicated in the progression of the disease and in the development of irreversible heart failure. In fact, an improvement of cardiac function was observed in none of our pts with TNFa overexpression.
Among viral myocarditis cases, the role of TNFa has been evaluated only in enteroviral myocarditis, both in experimental studies 32, 45 and human forms, 9 and recently also in a few pts with parvovirus B19 myocarditis. 46 In our study, we demonstrated that TNFa was significantly more expressed in viral myocarditis than in nonviral forms (16/20 vs 3/18, P ¼ 0.01), regardless of the viral etiology: capside or viral proteins have been demonstrated to be responsible for the attraction mainly of Th1 cells with consequently over-release of specific proinflammatory cytokines, just including TNFa.
Concerning the cell origin of TNFa, activated macrophages as well as lymphocytes and endothelial cells are considered the principal source in the course of myocarditis. 39 Several studies have demonstrated that in different cardiac-related pathologic conditions (congestive heart failure, myocarditis, dilated cardiomyopathy, ischemic heart disease, and septic cardiomyopathy) cardiac myocytes are actively involved in cytokine bio- synthesis. 13, 47 Our immunohistochemical analysis confirmed that the cellular source of TNFa protein was not only macrophages and mononuclear cells but also the cardiac myocytes themselves. Thus, TNFa produced by myocytes might have an autocrine effect, thus contributing to the progression of myocyte damage.
The direct intramyocardial evaluation of TNFa, with molecular techniques and immunohistochemistry, appears undoubtedly more satisfactory than circulating levels which may not reflect the specific targeted organs. 48 Furthermore, in congestive heart failure some authors have demonstrated that there is no significant correlation between the level of TNFa in the myocardium and the levels in plasma, probably because of its multiple sites of production. 39 Consequently, TNFa expression in our study was restricted to intramyocardial cytokine detection. A significant more prominent myocardial damage and wellevident inflammation was observed in TNFapositive than TNFa-negative myocarditis. The severe myocyte damage may be either caused by TNFa directly and by inflammatory cells that are recruited by TNFa, by the expression of other cytokines, or by the induction of NOS and the generation of free radicals.
A higher level of TNFa expression was recently reported in biopsies from pts affected by myocarditis with more extensive necrosis and inflammation; the authors noted a marked decrease of TNFa expression when cellular infiltration had become reduced. 49 However, viral etiology of myocarditis was not investigated at that time.
In our clinical study, we have also demonstrated an overexpression of TNFRI. Several experimental studies have shown the potential importance of TNFRI in signaling the negative inotropic effects of TNFa. TNFRI-deficient transgenic mice are resistant to the toxic effects of systemic TNF-a as well as to the systemic toxicity of lipopolysaccharide or Staphylococcus aureus enterotoxin B. 50, 51 On the other hand, other comparable studies on TNFRII-deficient mice showed that even though the mice were less sensitive to the toxic effects of systemic TNFa, they were not completely resistant to the adverse effects of TNFa as were the TNFRI-deficient mice. 52 The finding of intramyocardial TNFa in viral myocarditis provides not only new insights to the pathogenesis of viral forms but also suggests new targets for therapeutic intervention. Two large randomized clinical trials in human heart failure, aimed at determining the effect, of potent antiTNFa-blocking agents (etanercept and infliximab) on mortality, failed to demonstrate clinical benefit. 53 New approaches should be planned in the future focusing on myocarditis and intramyocardial TNFa overexpression.
